Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus
A relatively new addition to the arsenal of antidiabetic compounds studied in relation to Type 2 Diabetes mellitus (T2DM) have been the incretin mimetics, a group of substances that appear to work on the glucagon-like peptide-1 (GLP-1) receptor and enhance insulin secretion from the pancreatic -cells in a glucose-dependent manner, possibly more potently in hyperglycemic conditions, while suppressing glucagon secretion at the same time
Contraindications include: Known hypersensitivity to PT-141 or similar peptides History of cardiovascular events such as stroke or myocardial infarction Uncontrolled hypertension Pregnancy or breastfeeding Active liver or kidney disease If you have any chronic health conditions or are taking other medications, speak with a qualified provider before starting PT-141
The reduced food volume makes every bite count more, not less
A Glutathione deficiency can contribute to diseases such as Alzheimers, liver disease, cystic fibrosis, sickle cell anemia, HIV, AIDS and stroke
US$ 22.16
US$ 25.81
US$ 29.51
US$ 21.30
US$ 24.38
US$ 27.53
US$ 24.67
US$ 25.04
